Therapeutics: Potassium channel Kv7.3 (KCNQ3)

Neurology

INDICATION: Depression

Mouse studies suggest promoting KCNQ3 expression or opening potassium channels could help treat major depressive disorder (MDD). In

Read the full 197 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE